These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mammography screening in the county of Fyn. November 1993-December 1999. Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252 [TBL] [Abstract][Full Text] [Related]
3. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657 [TBL] [Abstract][Full Text] [Related]
4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
5. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study. Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817 [TBL] [Abstract][Full Text] [Related]
6. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501 [TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274 [TBL] [Abstract][Full Text] [Related]
8. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia. Matkowski R; Szynglarewicz B Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of the results of mammography screening in Dubrovnik-Neretva County in the 2006-2009 period]. Dzono-Boban A; Mratović MC; Masanović M Acta Med Croatica; 2010 Dec; 64(5):453-9. PubMed ID: 21692270 [TBL] [Abstract][Full Text] [Related]
10. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA; Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620 [TBL] [Abstract][Full Text] [Related]
11. Responding to the challenges of breast cancer in egypt and other arab countries. El Saghir NS J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588 [TBL] [Abstract][Full Text] [Related]
12. Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women. Venturini E; Losio C; Panizza P; Rodighiero MG; Fedele I; Tacchini S; Schiani E; Ravelli S; Cristel G; Panzeri MM; De Cobelli F; Del Maschio A Radiology; 2013 Aug; 268(2):347-55. PubMed ID: 23579052 [TBL] [Abstract][Full Text] [Related]
13. Mammographic breast density: How it affects performance indicators in screening programmes? Posso M; Louro J; Sánchez M; Román M; Vidal C; Sala M; Baré M; Castells X; Eur J Radiol; 2019 Jan; 110():81-87. PubMed ID: 30599878 [TBL] [Abstract][Full Text] [Related]
14. Mammography screening: A major issue in medicine. Autier P; Boniol M Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205 [TBL] [Abstract][Full Text] [Related]
16. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501 [TBL] [Abstract][Full Text] [Related]
17. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459 [TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]